Insider Selling: Paysign, Inc. (NASDAQ:PAYS) CEO Sells $131,760.00 in Stock

Paysign, Inc. (NASDAQ:PAYS) CEO Mark Newcomer sold 36,000 shares of the stock in a transaction on Wednesday, October 23rd. The shares were sold at an average price of $3.66, for a total value of $131,760.00. Following the completion of the sale, the chief executive officer now owns 9,336,886 shares of the company’s stock, valued at approximately $34,173,002.76. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Mark Newcomer also recently made the following trade(s):

• On Monday, October 21st, Mark Newcomer sold 22,000 shares of Paysign stock. The stock was sold at an average price of $3.75, for a total value of $82,500.00.
• On Monday, September 23rd, Mark Newcomer sold 50,000 shares of Paysign stock. The shares were sold at an average price of $4.25, for a total value of $212,500.00.
• On Thursday, September 19th, Mark Newcomer sold 1,500 shares of Paysign stock. The stock was sold at an average price of $4.50, for a total value of $6,750.00.
• On Friday, September 13th, Mark Newcomer sold 1,500 shares of Paysign stock. The shares were sold at an average price of $4.50, for a total transaction of $6,750.00.
• On Monday, August 5th, Mark Newcomer sold 69,593 shares of Paysign stock. The stock was sold at an average price of $4.54, for a total transaction of $315,952.22.

Paysign Stock Performance

Shares of PAYS opened at $3.71 on Friday. Paysign, Inc. has a one year low of $1.70 and a one year high of $5.59. The stock has a 50-day moving average price of $4.19 and a 200 day moving average price of $4.39. The company has a market capitalization of $196.28 million, a P/E ratio of 28.50 and a beta of 0.96.

Paysign (NASDAQ:PAYS) last released its earnings results on Wednesday, July 31st. The company reported $0.01 EPS for the quarter. The company had revenue of $14.33 million during the quarter, compared to analysts’ expectations of $14.07 million. Paysign had a return on equity of 32.55% and a net margin of 14.42%. As a group, equities research analysts forecast that Paysign, Inc. will post 0.21 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its position in shares of Paysign by 3.0% during the first quarter. Vanguard Group Inc. now owns 1,649,043 shares of the company’s stock worth $6,035,000 after purchasing an additional 48,489 shares during the last quarter. Renaissance Technologies LLC raised its stake in Paysign by 25.0% during the second quarter. Renaissance Technologies LLC now owns 1,504,380 shares of the company’s stock valued at $6,484,000 after buying an additional 301,000 shares in the last quarter. Joule Financial LLC bought a new position in Paysign during the 3rd quarter worth approximately $1,478,000. Dimensional Fund Advisors LP grew its position in shares of Paysign by 51.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 116,779 shares of the company’s stock worth $502,000 after acquiring an additional 39,710 shares in the last quarter. Finally, Sanctuary Advisors LLC acquired a new position in shares of Paysign in the 2nd quarter worth approximately $512,000. 25.89% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Barrington Research reaffirmed an “outperform” rating and set a $7.00 price target on shares of Paysign in a research note on Friday, June 28th.

Paysign Company Profile

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.